Similar articles

• Protective immunity evoked by locally administered group A streptococcal vaccines in mice.

  Bronze MS, McKinsey DS, Beachey EH, Dale JB. Bronze MS, et al. J Immunol. 1988 Oct 15;141(8):2767-70. J Immunol. 1988. PMID: 3049817
• Intranasal immunisation of mice with a streptococcal peptide-based vaccine.

  Relf W, Hayman W, Russell-Jones G, Good M. Relf W, et al. Adv Exp Med Biol. 1997;418:859-61. doi: 10.1007/978-1-4899-1825-3_204. Adv Exp Med Biol. 1997. PMID: 9331788 No abstract available.
• [Further study of the prevention of streptococcal infections in experiments on monkeys].

  Keller V, Dzhikidze EK, Voskanian NA, Kiunemund O, Knol' G. Keller V, et al. Vestn Akad Med Nauk SSSR. 1986;(3):66-8. Vestn Akad Med Nauk SSSR. 1986. PMID: 3518270 Russian. No abstract available.
• Prospects for a group A streptococcal vaccine.

  McMillan DJ, Chhatwal GS. McMillan DJ, et al. Curr Opin Mol Ther. 2005 Feb;7(1):11-6. Curr Opin Mol Ther. 2005. PMID: 15732524 Review.
• Group A streptococcal M proteins: virulence factors and protective antigens.

  Robinson JH, Kehoe MA. Robinson JH, et al. Immunol Today. 1992 Sep;13(9):362-7. doi: 10.1016/0167-5699(92)90173-5. Immunol Today. 1992. PMID: 1281632 Review.